Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Acq. announced
Quarterly results
Director departure
CC transcript

PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/21/2015 8-K Quarterly results
02/25/2015 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "AMENDMENT NO. 5 AMENDMENT NO. 5, dated as of February 20, 2015 , by and among PAR PHARMACEUTICAL COMPANIES, INC., a Delaware corporation , the Revolving Credit Lenders party hereto, and BANK OF AMERICA, N.A. , as administrative agent under the Credit Agreement, dated as of September 28, 2012 , among the Parent Borrower, PAR PHARMACEUTICAL, INC., a Delaware corporation , SKY GROWTH INTERMEDIATE HOLDINGS II CORPORATION, a Delaware corporation , BANA, as administrative agent under the Loan Documents, Swing Line Lender and L/C Issuer, each lender from time to time party thereto , and the other parties thereto from time to time. Capitalized terms used and not otherwise defined herein shall have the meanings assigned to them in the Credit Agreement. WHEREAS, Section 10.01 of the Credit Agreement...",
"Amendment No. 6 to the Credit Agreement among the Borrowers, Holdings, certain subsidiaries of the Company party thereto, BANA, as administrative agent and BANA, Goldman Sachs Bank USA and Deutsche Bank Securities Inc., as lead arrangers, which amends the Amended Credit Agreement"
02/10/2015 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Selected Information of Par Pharmaceutical Companies, Inc. provided to Prospective Debt Financing Sources"
09/22/2014 8-K Other Events
02/20/2014 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs: "AMENDMENT NO. 4 AMENDMENT NO. 4, dated as of February 20, 2014 , by and among PAR PHARMACEUTICAL COMPANIES, INC., a Delaware corporation , PAR PHARMACEUTICAL, INC., a Delaware corporation , SKY GROWTH INTERMEDIATE HOLDINGS II CORPORATION, a Delaware corporation , the Subsidiary Guarantors party hereto, BANK OF AMERICA, N.A. , as administrative agent , BANA, Goldman Sachs Bank USA and Deutsche Bank Securities Inc. , as Lead Arrangers under the Credit Agreement, dated as of September 28, 2012 , among the Parent Borrower, the Co-Borrower, Holdings, BANA, as administrative agent under the Loan Documents, Swing Line Lender and L/C Issuer, each lender from time to time party thereto , and the other parties thereto from time to time. Capitalized terms used and not otherwise defined herein shall h...",
"INCREMENTAL TERM B-2 LOAN JOINDER AGREEMENT JOINDER AGREEMENT, dated as of February 20, 2014 , by and among the Incremental Term Lender party hereto , PAR PHARMACEUTICAL COMPANIES, INC. , PAR PHARMACEUTICAL, INC. , the other Loan Parties party hereto, BANK OF AMERICA, N.A. , as Administrative Agent , BANA and Goldman Sachs Bank USA . RECITALS:"
02/19/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/29/2014 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Selected Information of Par Pharmaceutical Companies, Inc. provided to Prospective Debt Financing Sources"
01/21/2014 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger by and among Pharmaceutical Companies, Inc., Juniper Mergeco, Inc., JHP Group Holdings, Inc. and WP JHP Representative, LLC",
"Par Pharmaceutical to Acquire JHP Pharmaceuticals"
10/02/2012 8-K Form 8-K - Current report
10/02/2012 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
09/27/2012 8-K Submission of Matters to a Vote of Security Holders
09/11/2012 8-K Regulation FD Disclosure, Financial Statements and Exhibits
09/10/2012 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Selected Information Provided to Prospective Debt Financing Sources"
09/06/2012 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Selected Information Provided to Prospective Debt Financing Sources"
08/27/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "PAR PHARMACEUTICAL COMPANIES ANNOUNCES THE EXPIRATION OF THE “GO SHOP” PERIOD, RECEIPT OF EARLY TERMINATION OF HSR WAITING PERIOD AND SPECIAL MEETING DATE"
08/02/2012 8-K Quarterly results
Docs: "PAR PHARMACEUTICAL COMPANIES REPORTS SECOND QUARTER 2012 RESULTS"
07/16/2012 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Agreement and Plan of Merger, by and among Par Pharmaceutical Companies, Inc., Sky Growth Holdings Corporation and Sky Growth Acquisition Corporation",
"Amendment No. 1, to Rights Agreement, by and between the Company and American Stock Transfer & Trust Company",
"PAR PHARMACEUTICAL COMPANIES ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY TPG",
"Communication to Employees"
05/21/2012 8-K Form 8-K - Current report
05/08/2012 8-K Quarterly results
Docs: "PAR PHARMACEUTICAL COMPANIES REPORTS FIRST QUARTER 2012 RESULTS"
02/28/2012 8-K Form 8-K - Current report
02/02/2012 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Consent of Melby and Meador Accountancy Corp",
"The audited Consolidated Financial Statements of Anchen listed in Item 9.01 (a) above",
"The unaudited Condensed Consolidated Financial Statements of Anchen listed in Item 9.01 (a) above",
"Unaudited pro forma condensed combined financial information listed in item 9.01 (b) above"
01/06/2012 8-K Form 8-K - Current report
11/22/2011 8-K Form 8-K - Current report
11/18/2011 8-K Form 8-K - Current report
11/02/2011 8-K Form 8-K - Current report
08/24/2011 8-K Form 8-K - Current report
08/03/2011 8-K Quarterly results
Docs: "PAR PHARMACEUTICAL COMPANIES REPORTS SECOND QUARTER 2011 RESULTS"
05/23/2011 8-K Form 8-K - Current report
05/05/2011 8-K Form 8-K - Current report
02/24/2011 8-K Form 8-K - Current report
01/12/2011 8-K Form 8-K - Current report
12/17/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/03/2010 8-K Form 8-K - Current report
10/06/2010 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy